Sequenom Earnings Preview: Can This Streak Finally End?

Sequenom (NASDAQ:SQNM) will report earnings after markets close on Wednesday, July 24th. Sequenom Inc. is a molecular diagnostic testing and genetics analysis company. The Company provides services, diagnostic testing, applications and genetic analysis products. Sequenom’s products translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.

Here is your Cheat Sheet to Sequenom Earnings:

Earnings Expectations: Analysts expect earnings of $-0.22 per share on revenues of $46.25 million.

Analyst Trends:

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a loss of $0.2 to a loss $0.19. For the current year, the average estimate is a loss of $0.81, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Sequenom has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 47 38 47 56 90
Diluted EPS ($) -0.83 -1.16 -1.69 -0.75 -1.03

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012 Mar. 31, 2013
Revenue ($) in millions 18.25 22.85 33.67 38.50
Diluted EPS ($) -0.26 -0.26 -0.29 -0.26

Past Performance:
Sequenom has missed analyst estimates 4 times in the past four quarters. Shareholders could expect a bust if the company misses estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]